{"id":39933,"date":"2018-03-01T21:56:07","date_gmt":"2018-03-02T02:56:07","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=topics&#038;p=39933"},"modified":"2025-11-03T15:04:08","modified_gmt":"2025-11-03T20:04:08","slug":"dcc-gynecologic-oncology-standards","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/","title":{"rendered":"Normes pancanadiennes en mati\u00e8re de gyn\u00e9co-oncologie"},"content":{"rendered":"<p>Publi\u00e9 par le Partenariat en mars\u00a02018, ce document fournit des directives de haut niveau ainsi qu\u2019une r\u00e9flexion sur les exigences et les ressources fondamentales \u00e0 mettre en place afin d\u2019am\u00e9liorer les soins de chirurgie oncologique et leurs r\u00e9sultats.<\/p>\n<p>Les recommandations concr\u00e8tes que renferme le document visent \u00e0 combler les lacunes actuelles et \u00e0 am\u00e9liorer la qualit\u00e9 des soins offerts aux patientes souffrant de cancers gyn\u00e9cologiques. Bien entendu, ces normes devront \u00eatre adapt\u00e9es aux syst\u00e8mes de sant\u00e9 locaux.<\/p>\n<p>L\u2019introduction du document souligne les faits suivants\u00a0:<\/p>\n<ul>\n<li>En 2010, 82\u00a0885 cas de cancer ont \u00e9t\u00e9 signal\u00e9s au Canada chez les femmes, dont 12\u00a0% touchaient le syst\u00e8me reproducteur.<\/li>\n<li>Dans 9\u00a0cas sur 10, il s\u2019agissait de cancers de l\u2019ut\u00e9rus, de l\u2019ovaire et du col de l\u2019ut\u00e9rus.<\/li>\n<li>Toujours en 2010, le cancer de l\u2019ovaire a \u00e9t\u00e9 \u00e0 l\u2019origine du plus grand nombre de d\u00e9c\u00e8s signal\u00e9s, soit 9,5\u00a0femmes sur 100\u00a0000.<\/li>\n<li>Selon les statistiques canadiennes de 2010, le cancer de l\u2019ut\u00e9rus est celui des cancers du syst\u00e8me reproducteur qui a \u00e9t\u00e9 le plus souvent diagnostiqu\u00e9, avec un taux de 30,3\u00a0nouveaux cas pour 100\u00a0000\u00a0femmes.<\/li>\n<li>L\u2019\u00e2ge m\u00e9dian des femmes d\u00e9c\u00e9d\u00e9es d\u2019un cancer du col de l\u2019ut\u00e9rus a diminu\u00e9 en raison de l\u2019augmentation du taux de survie avec l\u2019\u00e2ge.<\/li>\n<\/ul>\n<div class=\"related-stats blue col-sm-12 col-md-12 col-lg-12 display-left\"><div class=\"stats-header\">9 cas sur 10<\/div>   <div class=\"stats-sub-header\">concernant l\u2019appareil reproducteur \u00e9taient des cancers de l\u2019ut\u00e9rus, de l\u2019ovaire et du col de l\u2019ut\u00e9rus<\/div>\n                    <\/div>\n<p>Ce document porte notamment sur\u00a0:<\/p>\n<ul>\n<li>les tumeurs malignes gyn\u00e9cologiques en g\u00e9n\u00e9ral;<\/li>\n<li>l\u2019acc\u00e8s rapide aux traitements et aux soins en p\u00e9riode pr\u00e9, per et postop\u00e9ratoire;<\/li>\n<li>la formation et le maintien des comp\u00e9tences des gyn\u00e9cologues oncologues;<\/li>\n<li>l\u2019acc\u00e8s aux services et \u00e0 l\u2019\u00e9quipement (comme l\u2019acc\u00e8s \u00e0 des oncologues, \u00e0 des consultants et \u00e0 des professionnels param\u00e9dicaux);<\/li>\n<li>les ressources offertes aux patientes et \u00e0 leur famille (p.\u00a0ex., des programmes sur les cancers h\u00e9r\u00e9ditaires);<\/li>\n<li>les processus ax\u00e9s sur la qualit\u00e9 (notamment des tables rondes multidisciplinaires).<\/li>\n<\/ul>\n<p>Le document s\u2019adresse en premier lieu aux gyn\u00e9cologues oncologues du Canada. Viennent ensuite les ministres de la Sant\u00e9, ainsi que les autres m\u00e9decins et sp\u00e9cialistes participant aux soins (p.\u00a0ex., les anesth\u00e9sistes, les radiologistes et les pathologistes). D\u2019autres utilisateurs pourraient tirer parti de ce document, notamment des chirurgiens d\u2019autres pays.<\/p>\n<p>L\u2019\u00e9laboration de ces normes repose sur des analyses environnementales, des revues de la documentation et un consensus d\u2019experts s\u2019appuyant sur des donn\u00e9es probantes.\u00a0 Ce document met l\u2019accent sur bon nombre de sujets essentiels comme le syst\u00e8me du Coll\u00e8ge royal des m\u00e9decins et chirurgiens du Canada (CRMCC) pour l\u2019\u00e9valuation et la certification officielle de la formation en gyn\u00e9co-oncologie.<\/p>\n<p><strong>Document \u00e0 t\u00e9l\u00e9charger<\/strong><\/p>\n<div class=\"documents col-md-12\"><div>\n                                <i class=\"fas fa-file-pdf document-icon\"><\/i>\n                                <div class=\"document-details\">\n                                    <a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2019\/01\/Pan-canadian-standards-gynecologic-oncology-FR.pdf\" target=\"_blank\">Normes pancanadiennes en mati\u00e8re de gyn\u00e9co-oncologie<\/a><p class=\"file-information\">Taille du fichier 3 MB<\/p>         <\/div>\n                            <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Publi\u00e9 par le Partenariat en mars\u00a02018, ce document fournit des directives de haut niveau ainsi qu\u2019une r\u00e9flexion sur les exigences et les ressources fondamentales \u00e0 mettre en place afin d\u2019am\u00e9liorer les soins de chirurgie oncologique et leurs r\u00e9sultats. Les recommandations concr\u00e8tes que renferme le document visent \u00e0 combler les lacunes actuelles et \u00e0 am\u00e9liorer la [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":0,"menu_order":0,"template":"","topics_tags":[],"type-of-care":[1640],"cancer-continuum":[1643],"cancer-system-measurement":[],"dbt-cancer-site":[474,480,507],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-39933","topics","type-topics","status-publish","hentry","type-of-care-surgery-fr","cancer-continuum-treatment-fr","dbt-cancer-site-dbv-cervical-fr","dbt-cancer-site-dbv-gynecology-fr","dbt-cancer-site-dbv-ovarian-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Normes pancanadiennes en mati\u00e8re de gyn\u00e9co-oncologie - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Publi\u00e9 par le Partenariat en mars\u00a02018, ce document fournit des directives de haut niveau ainsi qu\u2019une r\u00e9flexion sur les exigences et les ressources fondamentales \u00e0 mettre en place afin d\u2019am\u00e9liorer les soins de chirurgie oncologique et leurs r\u00e9sultats. Les recommandations concr\u00e8tes que renferme le document visent \u00e0 combler les lacunes actuelles et \u00e0 am\u00e9liorer la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-03T20:04:08+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/dcc-gynecologic-oncology-standards\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/dcc-gynecologic-oncology-standards\\\/\",\"name\":\"Normes pancanadiennes en mati\u00e8re de gyn\u00e9co-oncologie - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2018-03-02T02:56:07+00:00\",\"dateModified\":\"2025-11-03T20:04:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/dcc-gynecologic-oncology-standards\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/dcc-gynecologic-oncology-standards\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/dcc-gynecologic-oncology-standards\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Normes pancanadiennes en mati\u00e8re de gyn\u00e9co-oncologie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/","og_locale":"fr_FR","og_type":"article","og_title":"Normes pancanadiennes en mati\u00e8re de gyn\u00e9co-oncologie - Canadian Partnership Against Cancer","og_description":"Publi\u00e9 par le Partenariat en mars\u00a02018, ce document fournit des directives de haut niveau ainsi qu\u2019une r\u00e9flexion sur les exigences et les ressources fondamentales \u00e0 mettre en place afin d\u2019am\u00e9liorer les soins de chirurgie oncologique et leurs r\u00e9sultats. Les recommandations concr\u00e8tes que renferme le document visent \u00e0 combler les lacunes actuelles et \u00e0 am\u00e9liorer la [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-11-03T20:04:08+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/","name":"Normes pancanadiennes en mati\u00e8re de gyn\u00e9co-oncologie - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2018-03-02T02:56:07+00:00","dateModified":"2025-11-03T20:04:08+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/dcc-gynecologic-oncology-standards\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Normes pancanadiennes en mati\u00e8re de gyn\u00e9co-oncologie"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/39933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=39933"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=39933"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=39933"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=39933"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=39933"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=39933"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=39933"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=39933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}